ARTICLE | Clinical News
Olaptesed pegol: Additional Phase IIa data
July 28, 2014 7:00 AM UTC
Data from 20 evaluable patients with relapsed MM in an open-label, dose-escalation, European Phase IIa trial showed that olaptesed pegol in combination with Velcade bortezomib and dexamethasone led t...